Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$3.23B |
| 2 |
Corteva
CTVA
|
+$1.64B |
| 3 |
Newmont
NEM
|
+$1.04B |
| 4 |
Microsoft
MSFT
|
+$981M |
| 5 |
Alcon
ALC
|
+$794M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$2.79B |
| 2 |
JPMorgan Chase
JPM
|
+$950M |
| 3 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$922M |
| 4 |
Apple
AAPL
|
+$662M |
| 5 |
Oracle
ORCL
|
+$661M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.43% |
| 2 | Financials | 15.04% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Legacy Housing
LEGH
$648M
| $2.96M | ﹤0.01% |
237,459
+23,332
| +11% | +$283K |
|
3352
Everspin Technologies
MRAM
$408M
| $2.95M | ﹤0.01% |
452,054
-19,160
| -4% | -$145K |
|
|
GNCA
3353
DELISTED
Genocea Biosciences, Inc.
GNCA
| $2.95M | ﹤0.01% |
751,377
+584,821
| +351% | +$3.05M |
|
|
MLNT
3354
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $2.94M | ﹤0.01% |
442,455
+218,085
| +97% | +$830K |
|
3355
Universal Technical Institute
UTI
$2.33B
| $2.93M | ﹤0.01% |
854,675
+2,100
| +0.2% | +$7.12K |
|
|
AIOT
3356
PowerFleet Inc
AIOT
$576M
| $2.92M | ﹤0.01% |
496,590
-143,000
| -22% | -$779K |
|
3357
Stoke Therapeutics
STOK
$1.97B
| $2.92M | ﹤0.01% |
+100,000
| New | +$2.69M |
|
3358
AmeriServ Financial
ASRV
$74.6M
| $2.91M | ﹤0.01% |
701,773
+3,995
| +0.6% | +$16.5K |
|
3359
Ultrapar
UGP
$6.75B
| $2.91M | ﹤0.01% |
555,560
-79,226
| -12% | -$430K |
|
|
NTGN
3360
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| $2.9M | ﹤0.01% |
612,398
+21,387
| +4% | +$120K |
|
3361
Cartesian Therapeutics
RNAC
$237M
| $2.9M | ﹤0.01% |
54,010
+3,660
| +7% | +$249K |
|
3362
LiveOne
LVO
$59.9M
| $2.9M | ﹤0.01% |
69,829
+14,641
| +27% | +$647K |
|
|
GOLD
3363
Gold.com Inc
GOLD
$1.24B
| $2.87M | ﹤0.01% |
439,670
+52,400
| +14% | +$317K |
|
|
NVTR
3364
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $2.86M | ﹤0.01% |
854,198
-22
| -0% | -$139 |
|
|
MJCO
3365
DELISTED
Majesco
MJCO
| $2.86M | ﹤0.01% |
306,931
+34,299
| +13% | +$275K |
|
|
BAS
3366
DELISTED
Basis Energy Services, Inc.
BAS
| $2.84M | ﹤0.01% |
1,496,762
+442,189
| +42% | +$1.15M |
|
3367
BioXcel Therapeutics
BTAI
$26.6M
| $2.84M | ﹤0.01% |
16,206
+5,060
| +45% | +$857K |
|
3368
Smith Micro Software
SMSI
$15.7M
| $2.84M | ﹤0.01% |
23,343
+4,851
| +26% | +$591K |
|
3369
Research Frontiers
REFR
$16.3M
| $2.84M | ﹤0.01% |
852,340
+303,703
| +55% | +$860K |
|
|
NIHD
3370
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $2.83M | ﹤0.01% |
1,677,423
-50,663
| -3% | -$96.5K |
|
3371
Star Group
SGU
$420M
| $2.83M | ﹤0.01% |
+283,329
| New | +$2.75M |
|
|
RIBT
3372
DELISTED
RiceBran Technologies
RIBT
| $2.82M | ﹤0.01% |
97,052
+2,711
| +3% | +$81.2K |
|
3373
HUTCHMED
HCM
$2.01B
| $2.82M | ﹤0.01% |
128,207
-13,955
| -10% | -$398K |
|
3374
Tencent Music
TME
$15.8B
| $2.8M | ﹤0.01% |
187,113
-9,077
| -5% | -$143K |
|
|
BCEL
3375
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $2.77M | ﹤0.01% |
+146,975
| New | +$2.65M |
|
Similar funds
Vanguard Group's Q2 2019 Portfolio in Review
As of Q2 2019, Vanguard Group held 4,245 positions worth $2.66T, up 4.3% from $2.55T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q2 2019: portfolio turnover was 4.8%. Vanguard Group opened 126 new positions and exited 76, leaving the 4,245-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q2 2019 buy was Dow Inc: 61,095,269 shares worth $3.01B.
- Vanguard Group added most to Newmont in Q2 2019, an estimated $1.04B increase.
- Vanguard Group's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $2.79B.
- Vanguard Group fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $922M.
- Vanguard Group's ten largest holdings make up 15% of its $2.66T portfolio in Q2 2019.
- Vanguard Group opened 126 new positions and closed 76 in Q2 2019.
- Vanguard Group's portfolio value rose 4.3% quarter-over-quarter to $2.66T.
Based on Vanguard Group's 13F filing for Q2 2019, filed 14 Aug 2019.